Cost of Revenue of Pyxis Oncology, Inc. from 31 Mar 2024 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Pyxis Oncology, Inc. annual and quarterly Cost of Revenue in USD history and change rate from 31 Mar 2024 to 31 Dec 2024.
  • Pyxis Oncology, Inc. Cost of Revenue for the quarter ending 31 Mar 2024 was $475,000.
Source SEC data
View on sec.gov
Cost of Revenue, Annual (USD)
Cost of Revenue, Quarterly (USD)

Pyxis Oncology, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $475,000 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY

Pyxis Oncology, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $475,000 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.